ICON plc

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Agilent Technologies

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Amgen Italia

Siamo al servizio dei pazienti. Da quasi 40 anni siamo impegnati a sviluppare il potenziale della biologia per rispondere ai tanti bisogni medici, in aree terapeutiche di grande impatto per la sanità pubblica, come oncologia ed ematologia, cardiovascolare, osteoporosi, reumatologia, malattie infiammatorie, nefrologia. Il nostro approccio, rappresentato efficacemente dall’espressione “Biology First”, si avvale di risorse quali la genetica avanzata e analizza in profondità i processi biologici dell’organismo umano, che provocano le malattie ma che, allo stesso tempo, contengono le potenziali soluzioni. Con sede principale a Thousand Oaks, in California, siamo tra i leader mondiali delle biotecnologie, con 20.000 dipendenti e una presenza in più di 100 Paesi in tutto il mondo. Anche in Italia Amgen è riconosciuta tra i Best Workplaces, un ambiente di lavoro che valorizza le giovani generazioni, che rappresentano ben il 23% dei collaboratori. Amgen è un’azienda inclusiva e capace di offrire stimolanti prospettive di sviluppo professionale, sostenute da innovativi piani di formazione. Leggi le linee guida della nostra community: https://www.amgen.it/linee-guida-per-utilizzo-dei-social-media/ Leggi la nostra informativa sulla privacy: https://www.amgen.it/it-IT/informativa-sulla-privacy

thermo fisher spectral cytometry

Revolutionary technology for Spectral Cytometry with NovaFluor™ fluorescent dyes and BigFoot Cell Sorter to fundamentally change flow cytometry panel design and analysis. Follow us and stay up-to-date on the best practices of spectral flow cytometry experimentation. Using the Phiton™ platform, The NovaFluor™ fluorescent labelled conjugated antibodies and the NovaFluor Conjugation Kits enable multiplexed detection using previously incompatible laser lines and provide cleaner, higher-dimensional analysis of single cells by flow cytometry. These fundamentally change flow cytometry panel design, with engineered excitation, emission, brightness and stability. The Bigfoot Spectral Cell Sorter supports configurations with up to nine lasers, delivering versatility for both standard fluorescence detection and spectral unmixing. Multiple scatter options enhance flexibility with simultaneous standard and small particle detection, multi-laser scatter detection, and polarization.

genentech medical

The official Genentech Medical LinkedIn page for sharing the latest scientific, medical, and clinical trial information with US healthcare professionals. • By interacting with this LinkedIn page, you confirm that you are a US healthcare professional. • There are regulations that govern our LinkedIn page. We reserve the right to engage with posts that follow our community guidelines (https://bit.ly/4aqwv2h). Not all posts will receive responses. Responses will be provided during business hours M-F, 5am to 5pm PT. • This page provides a platform for Genentech Medical Affairs to share scientific information, disease education, and clinical trial updates. We welcome your comments. Please stay on topic and refrain from using inappropriate language. • If you are aware of anyone that has experienced any adverse events related to a Genentech product, report them immediately to Genentech Drug Safety by emailing us_drug.safety@gene.com or calling 1-888-835-2555. You can also contact the FDA directly by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. We will report this adverse event to the FDA and may contact you with questions or request additional information. • Respect others’ privacy and do not share personal information that is not in the public domain. • Do not reference Genentech products and services or alternative therapeutic options or your posts may be deleted. • This page is for informational purposes only and is not a forum to solicit or give medical advice. • The sharing of content or links to third-party sites is not an indication of endorsement by Genentech and Genentech is not responsible for this content. • If you have a medical inquiry, contact our Medical Information team M-F, 5am to 5pm PT by calling 1-800-821-8590.